Exciting continuation! Shanghai Lujiazui Finance & Trade Zone Development Third Session: Discussing New Paradigms of Value-Driven Mergers and Acquisitions.

We will explore how traditional Industry companies can transform, issues related to mergers and acquisitions of listed companies, and the promotion of cross-industry merger synergies.

cls.cnMar 12 21:14 ET

The "hot battle" of humanoid robots has begun: frequent release of new products. Is the year of mass production really here? | Industry observation

① Siasun Robot&Automation and Zhiyuan Robot both launched new humanoid robots, and related Concept stocks rose in response; ② mass production of humanoid robots still faces challenges, and domestic manufacturers aim to produce thousands of units this year; ③ there are also disputes within the Industry regarding the implementation scenarios.

cls.cnMar 12 00:30 ET

In February, the auto market welcomed a "small spring": the sales of 12 listed in Hong Kong and A-share companies all saw year-on-year growth.

① The data from the Passenger Vehicle Association on March 10 shows that retail sales of passenger vehicles in February reached 1.386 million units, a year-on-year increase of 26.0%; the cumulative retail sales for January and February this year reached 3.179 million units, a year-on-year increase of 1.2%. ② According to statistics from financial reporters, the sales of 12 A/H listed auto companies in February all achieved year-on-year growth. Among them, BYD, Xpeng Motors, LEAPMOTOR, and BAIC BluePark New Energy Technology achieved multiple growth.

cls.cnMar 10 06:29 ET

The second session of the Shanghai Lujiazui Finance & Trade Zone Development financial salon: exploring new opportunities for the integration of AI and Capital Markets together.

Representatives from government departments, Financial Institutions, enterprises, industry associations, and research institutions will gather together to analyze AI technology trends and industry changes, and evaluate the opportunities and challenges in the new era of Capital Markets.

cls.cnMar 4 07:01 ET

Two Sessions Time | National People's Congress Representative, Lu Qingguo from Chenguang Biotech Group: Improve the quality standards of Chinese Patent Medicine, regulate the centralized procurement model for Traditional Chinese Medicine, and optimize the

① Lu Qingguo, Director of Chenguang Biotech Group and a representative of the National People's Congress, focused on several recommendations at this year's Two Sessions, including optimizing the procurement mechanism for Traditional Chinese Medicine, enhancing the quality standards for Chinese Patent Medicine, and standardizing the Traditional Chinese Medicine granule industry; ② In addition to recommendations related to the Traditional Chinese Medicine industry, Lu Qingguo prepared several suggestions on rural social retirement insurance, rural medical insurance, and increasing support for companies sanctioned by the United States.

cls.cnMar 2 21:09 ET

The American "god car" has unleashed its ultimate weapon.

Jump squat.

wallstreetcnFeb 28 01:35 ET